Genomic Profiling of Evolving Daptomycin Resistance in a Patient with Recurrent Staphylococcus argenteus Sepsis

Samantha Hao1, Mazin Abdelghany2, Amy Lyden1

  • 1Chan Zuckerberg Biohub, San Francisco, California, USA.

Insights

The first case of drug-resistant Staphylococcus argenteus developed in a patient treated for a vascular graft infection. Whole-genome sequencing revealed a mutation (MprF S337L) linked to resistance.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Staphylococcus argenteus is a recently identified species linked to invasive infections.
  • Antimicrobial resistance is a growing global health concern, particularly in staphylococcal species.

Observation:

  • A patient with a complex vascular graft infection was initially diagnosed with Staphylococcus aureus.
  • The patient underwent repeated treatment with daptomycin, a lipopeptide antibiotic.

Findings:

  • Longitudinal isolates revealed the emergence of daptomycin and vancomycin resistance in Staphylococcus argenteus.
  • Whole-genome sequencing identified the acquisition of the MprF S337L mutation.
  • This mutation is predicted to alter cell surface charge, potentially conferring resistance to cationic antimicrobial agents.

Implications:

  • This case highlights the potential for Staphylococcus argenteus to develop antimicrobial resistance.
  • Understanding resistance mechanisms like MprF S337L is crucial for managing complex infections.
  • The findings underscore the importance of accurate species identification and antimicrobial stewardship.